Morphine Extended-Release Capsules and Mycophenolic Acid Tablets
Determining the interaction of Morphine Extended-Release Capsules and Mycophenolic Acid Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: morphine
Brand name: Arymo ER, Kadian, MorphaBond ER, MS Contin, Avinza, Duramorph PF, Infumorph, Mitigo, RMS, Roxanol
Synonyms: Morphine, Morphine (Systemic)
Generic Name: mycophenolic acid
Brand name: Myfortic
Synonyms: Mycophenolic acid, Mycophenolate Tablets Delayed Release
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Morphine Extended-Release Capsules-Mycostatin (Nystatin Oral Suspension)
- Morphine Extended-Release Capsules-Mycostatin (Nystatin Tablets and Capsules)
- Morphine Extended-Release Capsules-Mycostatin Suspension
- Morphine Extended-Release Capsules-Mydayis
- Morphine Extended-Release Capsules-Mydayis ER Capsules
- Morphine Extended-Release Capsules-Mydfrin
- Mycophenolic Acid Tablets-Morphine Immediate-Release Tablets and Capsules
- Mycophenolic Acid Tablets-Morphine injection
- Mycophenolic Acid Tablets-Morphine Injection PF
- Mycophenolic Acid Tablets-Morphine Long-Acting Tablets
- Mycophenolic Acid Tablets-Morphine Oral Concentrate (20 mg/mL)
- Mycophenolic Acid Tablets-Morphine Oral Solution